Global Health enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


34,473	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
127	127	230	425	767
22.7	22.7	1.1	−0.0	453
1,190	1,190	328	419	842
35,558	—	—	—	—
1,063	1,063	97.7	−5.3	75.0
₹1,323.40	—	—	—	—

5,174	5,174	3,715	3,325	3,270
23.0%	23.0%	8.8%	12.6%	25.8%
0.03×	—	—	—	—

7.59×	—	—	—	—
36.33×	—	—	—	—
48.55×	—	—	—	—
4,683	4,410	3,692	3,275	2,694
979	919	877	799	612
732	697	683	626	462
—	714	624	612	645
−124	−124	107	334	409
—	−133	93.5	320	383
—	838	517	279	236

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MEDANTA₹1,283.00

Global Health Ltd.

· Pharma & Health

₹ CrorePeersMAXHEALTH APOLLOHOSP FORTIS GLAXO ANTHEM AJANTPHARM IPCALAB ABBOTINDIAMcap ₹34,473 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	34,472.9
- Cash, Equiv & ST Investments	767.2	424.6	230.2	127.3	127.3
+ Minority Interest	452.8	-0.0	1.1	22.7	22.7
+ Total Debt	842.2	419.3	327.9	1,190.0	1,190.0
Enterprise Value	—	—	—	—	35,558.3
Net Debt (memo)	75.0	-5.3	97.7	1,062.7	1,062.7
EV per Share	—	—	—	—	1,323.40

Total Capital	3,270.4	3,324.9	3,715.4	5,174.3	5,174.3
Total Debt/Total Capital	25.75	12.61	8.82	23.00	23.00
Total Debt/EV	—	—	—	—	0.03

EV/Sales	—	—	—	—	7.59
EV/EBITDA	—	—	—	—	36.33
EV/EBIT	—	—	—	—	48.55
Reference Items — Trailing FY Values
Sales	2,694.2	3,275.1	3,692.3	4,410.3	4,683.4
EBITDA	612.2	799.1	877.1	919.1	978.8
EBIT	462.3	626.3	683.3	696.6	732.3
Operating Cash Flow	644.5	612.1	623.8	714.4	—
Free Cash Flow	408.5	333.5	107.2	-123.8	-123.8
FCFF (free cash flow to the firm)	383.2	320.0	93.5	-132.5	—
Capital Expenditure	236.0	278.6	516.5	838.2	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.